참고문헌
- Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101. https://doi.org/10.2307/2533446
- Bielack SS, Kempf-Bielack B, Delling G, et al (2002). Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1, 702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol, 20, 776-90. https://doi.org/10.1200/JCO.20.3.776
- Caronia D, Patino-Garcia A, Perez-Martinez A, et al (2011). Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: a pharmacogenetic study. PLoS One, 6, 26091. https://doi.org/10.1371/journal.pone.0026091
- DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. https://doi.org/10.1016/0197-2456(86)90046-2
- Hayes JD, Pulford DJ (1995). The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol, 30, 445-600. https://doi.org/10.3109/10409239509083491
- He JP, Hao Y, Wang XL, et al (2014). Review of the molecular pathogenesis of osteosarcoma. Asian Pac J Cancer Prev, 15, 5967-76. https://doi.org/10.7314/APJCP.2014.15.15.5967
- Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58. https://doi.org/10.1002/sim.1186
- Li JZ, Tian ZQ, Jiang SN, Feng T (2014). Effect of variation of ABCB1 and GSTP1 on osteosarcoma survival after chemotherapy. Genet Mol Res, 13, 3186-92. https://doi.org/10.4238/2014.April.25.3
- Li M, Zhu Y, Zhang H, et al (2014). Delivery of inhibitor of growth 4 (ING4) gene significantly inhibits proliferation and invasion and promotes apoptosis of human osteosarcoma cells. Sci Rep, 4, 7380. https://doi.org/10.1038/srep07380
- Liu S, Yi Z, Ling M, et al (2014). Predictive potential of ABCB1, ABCC3, and GSTP1 gene polymorphisms on osteosarcoma survival after chemotherapy. Tumour Biol, 35, 9897-904. https://doi.org/10.1007/s13277-014-1917-x
- Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
- Ottaviani G, Jaffe N (2009). The epidemiology of osteosarcoma. Cancer Treat Res, 152, 3-13. https://doi.org/10.1007/978-1-4419-0284-9_1
- Redlich G, Zanger UM, Riedmaier S, et al (2008). Distinction between human cytochrome P450 (CYP) isoforms and identification of new phosphorylation sites by mass spectrometry. J Proteome Res, 7, 4678-88. https://doi.org/10.1021/pr800231w
- Wei L, Song XR, Wang XW, Li M, WS Zu (2006). [Expression of MDR1 and GST-pi in osteosarcoma and soft tissue sarcoma and their correlation with chemotherapy resistance]. Zhonghua Zhong Liu Za Zhi, 28, 445-8.
- Windsor RE, Strauss SJ, Kallis C, Wood NE, Whelan JS (2012). Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study. Cancer, 118, 1856-67. https://doi.org/10.1002/cncr.26472
- Xiaohui S, Aiguo L, Xiaolin G, et al (2014). Effect of ABCB1 polymorphism on the clinical outcome of osteosarcoma patients after receiving chemotherapy. Pak J Med Sci, 30, 886-90.
- Yang J, Wang ZG, Cai HQ, Li YC, Xu YL (2013). Effect of variation of ABCB1 and ABCC3 genotypes on the survival of bone tumor cases after chemotherapy. Asian Pac J Cancer Prev, 14, 4595-8. https://doi.org/10.7314/APJCP.2013.14.8.4595
- Zhou SF, Di YM, Chan E, et al (2008). Clinical pharmacogenetics and potential application in personalized medicine. Curr Drug Metab, 9, 738-84. https://doi.org/10.2174/138920008786049302
피인용 문헌
- Association between ABCB1 polymorphisms and haplotypes and Alzheimer’s disease: a meta-analysis vol.6, pp.1, 2016, https://doi.org/10.1038/srep32708
- Advances and challenges in hereditary cancer pharmacogenetics vol.13, pp.1, 2017, https://doi.org/10.1080/17425255.2017.1233965